Search

everythinglearnresearchcommunity

for

Search:↓

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Androgens significantly affect female hair loss, and hormonal treatments may help.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Finasteride reduces hair growth and is safe for women with excessive hair.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Iraqi women with PCOS often have higher testosterone levels and obesity.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Young women with PCOS and no other heart risk factors have normal heart function.